Dear Colleagues, Dear Friends, Dear Everyone,

This new issue of the journal brings together the main discussions from last June’s meeting in Toulouse, where we gathered in a beautiful setting and enjoyed a wonderful evening together.
As usual, these meeting days gave us the opportunity to review both completed and upcoming clinical trials.
New studies have been launched, and we must continue our collective efforts to achieve patient enrolment.
I look forward to seeing you again at our next meeting in December in Charenton, which will also be an opportunity to renew the Board of Directors and for me to step down as President of the group.
GORTEC-ly yours

Dear colleagues, dear friends,
Clinical research is becoming increasingly challenging and complex, with ever-growing constraints for investigators, progressively more stringent regulations, and exponentially increasing costs for sponsors. As part of our academic mission, it is essential for GORTEC to preserve and strengthen our capabilities in order to effectively address all of these challenges.